We Are Known For Our

CREDIBILITYVERSATILITYEXPERTISECAPABILITYINTEGRITYRESPECTTRUSTRELATIONSHIPSCOLLABORATIONREPUTATIONINSIGHTSKNOWLEDGEHONESTY
SERVICES
GET IN TOUCH

  • Arvind Mani

    Managing Director

    Arvind Mani
    Managing Director

  • Sherry O'Quinn

    Managing Principal

    Sherry O’Quinn
    Managing Principal

  • Brad Alyward

    Principal Consultant

    Brad Alyward
    Principal Consultant

  • Anita Gadhok

    Senior Consultant

    Anita Gadhok
    Senior Consultant

  • Anita Carrie

    Senior Consultant, Health Technology Assessment (HTA)

    Anita Carrie
    Senior Consultant, Health Technology Assessment (HTA)

  • Roy Cairns

    Senior Consultant

    Roy Cairns
    Senior Consultant

MORSE Services

lightbulb-idea

STRATEGIC ADVICE

MORSE Consulting offers ongoing strategic advice to optimize the prospect of reimbursement success throughout the Canadian pharmaceutical lifecycle.
Image Not Found On Media Library

ANALYSES

MORSE Consulting develops tailored reimbursement assessments and analyses to meet a client’s evolving needs – from comprehensive reimbursement landscape assessments to detailed time-to-listing analyses.
teamwork-in-the-office

ADVISORY BOARDS

MORSE Consulting organizes, facilitates, and participates in numerous types of advisory boards. This includes negotiation simulation sessions which help clients gauge payer reaction to a range of proposals.
presentation-board-with-graph

TRAINING

MORSE Consulting delivers training sessions on the Canadian pharmaceutical reimbursement environment that can be customized for various target audiences.

MORSE Reports

NEW Canadian Reimbursement Trends and Timelines Report Released!

Industry Feedback...

“The market access timelines within Canada are a broad and important issue and therefore, there is significant value in providing this information to companies on a regular basis. Global head offices frequently have questions regarding the Canadian reimbursement processes particularly after HTA recommendation. This slide deck would be a valuable tool for market access groups and business units to answer these questions and set internal expectations.”

– General Manager
Ontario-based Pharmaceutical Company

 “In our world of market access we know the processes inside and out, but where the advantage of this MORSE report lies for individuals like myself is in painting the picture of the public reimbursement process and timelines with our internal commercial teams, senior management and global voices as we determine launch plans for products in Canada.”

– Public Affairs Lead
Ontario-based Pharmaceutical Company

“This report is a useful tool to sensitize stakeholders, in particular MORSE’s expertise will allow us to answer internal questions regarding pCPA negotiations and timing of the letter of intent.” 

– Market Access Director
Quebec-based Pharmaceutical Company

“When working with stakeholders, such as patient groups, the timeline content of the report would be useful in order to map out strategy and timing. Ultimately, it would facilitate coordination across many silos, including internally within the Canadian team, the global team and with external stakeholders such as patient groups and payers.”

– Director of Market Access & Government Affairs
Ontario-based Pharmaceutical Company

MORSE Signals

Timely and relevant updates related to the emerging developments in the Canadian pharmaceutical reimbursement landscape.

Impact of COVID19 on pCPA Negotiations Starting to Emerge

August 13, 2020
-
Market Access News

pan-Canadian Pharmaceutical Alliance (pCPA): July 2020 Trends and Insights   July 2020 Highlights: 6 products completed CADTH review 6 products initiated pCPA negotiations 7 negotiations were completed with … Read More →

Read More →
MORSE
Posted by MORSE
3 MIN READ

Some Positive Indicators as Number of Files Under Consideration Remains Flat – June 2020

July 28, 2020
-
Market Access News

pan-Canadian Pharmaceutical Alliance (pCPA): June 2020 Trends and Insights   June Highlights: 4 products completed CADTH review 7 products initiated pCPA negotiations 4 negotiations were completed with an … Read More →

Read More →
MORSE
Posted by MORSE
3 MIN READ

CADTH Pharmaceutical Reviews Update, Issue 16

July 10, 2020
-
Market Access News

Consultations on Enhanced and Aligned Review Processes and Program Updates.   CADTH released its Pharmaceutical Reviews Update — Issue 16 on June 25, 2020. It includes two consultations … Read More →

Read More →
MORSE
Posted by MORSE
5 MIN READ

MORSE Key

Pharmaceutical Market Access Events Calendar

No event found!
Load More

MORSE Careers

We are always looking for bright, passionate, and motivated individuals, so check out our open positions or send us your resumé.

Career Opportunity at MORSE For a Reimbursement Analyst

February 3, 2020
-
Careers, What's New

We are seeking an individual with similar values, a passion for learning and an interest in making a meaningful contribution to consulting projects and our overall...

Read More →
MORSE
Posted by MORSE
4 MIN READ
MORSE Consulting Inc. - Deciphering Pharmaceutical Market Access
css.php